Seeking to outpace the market, investors engage in the art of selecting individual stocks. The right picks can play a pivotal role in boosting your wealth.
As of close of business last night, Perspective Therapeutics Inc’s stock clocked out at $1.85, down -11.48% from its previous closing price of $2.09. In other words, the price has decreased by -$11.48 from its previous closing price. On the day, 0.73 million shares were traded. CATX stock price reached its highest trading level at $2.0899 during the session, while it also had its lowest trading level at $1.82.
Ratios:
To gain a deeper understanding of CATX’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 12.68 and its Current Ratio is at 12.68. In the meantime, Its Debt-to-Equity ratio is 0.01 whereas as Long-Term Debt/Eq ratio is at 0.01.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, H.C. Wainwright on March 13, 2025, initiated with a Buy rating and assigned the stock a target price of $10.
On March 07, 2025, Scotiabank started tracking the stock assigning a Sector Outperform rating and target price of $15.
BofA Securities Downgraded its Buy to Neutral on November 25, 2024, whereas the target price for the stock was revised from $24 to $5.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Mar 28 ’25 when Spoor Johan M. bought 22,026 shares for $2.24 per share. The transaction valued at 49,384 led to the insider holds 59,383 shares of the business.
Spoor Johan M. bought 4,650 shares of CATX for $10,288 on Mar 28 ’25. The Chief Executive Officer now owns 4,650 shares after completing the transaction at $2.21 per share. On Mar 31 ’25, another insider, Williamson Robert F III, who serves as the Director of the company, bought 38,145 shares for $2.14 each. As a result, the insider paid 81,775 and bolstered with 108,982 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CATX now has a Market Capitalization of 136995824 and an Enterprise Value of -85858096. For the stock, the TTM Price-to-Sale (P/S) ratio is 94.48 while its Price-to-Book (P/B) ratio in mrq is 0.45. Its current Enterprise Value per Revenue stands at -59.05 whereas that against EBITDA is 1.331.
Stock Price History:
The Beta on a monthly basis for CATX is 1.15, which has changed by -0.8741497 over the last 52 weeks, in comparison to a change of 0.05279863 over the same period for the S&P500. Over the past 52 weeks, CATX has reached a high of $19.05, while it has fallen to a 52-week low of $1.60. The 50-Day Moving Average of the stock is -26.37%, while the 200-Day Moving Average is calculated to be -76.53%.
Shares Statistics:
It appears that CATX traded 779.12K shares on average per day over the past three months and 1103020 shares per day over the past ten days. A total of 70.67M shares are outstanding, with a floating share count of 53.81M. Insiders hold about 27.34% of the company’s shares, while institutions hold 68.21% stake in the company. Shares short for CATX as of 1743379200 were 5710412 with a Short Ratio of 7.33, compared to 1740700800 on 5909500. Therefore, it implies a Short% of Shares Outstanding of 5710412 and a Short% of Float of 9.21.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
